GigaGen, Inc.

9 Marks

Corp.

First Filed:Aug 2, 2011Latest Filed:Nov 22, 2023Address:75 Shoreway Road, Suite A, San Carlos, CA 94070

Portfolio Overview

Registered

5(56%)

Dead

4(44%)

Top Classes

Class 5

Pharmaceuticals

3(33%)

Class 42

Software, IT Services & Scientific Research

3(33%)

Class 1

Industrial Chemicals & Adhesives

2(22%)

TTAB Proceedings

No litigation activity

Top Firms

Goodwin Procter LLP(Nov 2023)

Trademark Portfolio

9 results

(current & previous marks)

Refine by Mark/Description🔽

Filed

Registered

Last Activity

Filters

Ownership

Current9

Previous0

Status

Registered5

Pending0

Cancelled1

Abandoned3

Expired0

Mark Type

Word8

Stylized0

Design1

Combined0

NonVisual0

Class 12

Class 53

Class 91

Class 423

GIGA-564

Trademark

Word

REGISTERED

Owner:

Serial:98282853

Filed:Nov 22, 2023

Classes:5

Registration:7995835

Registered:Oct 21, 2025

Goods & Services

Pharmaceutical and therapeutic preparations for the treatment of oncological diseases and disorders, infectious diseases, immune deficiencies, and autoimmune diseases; therapeutic antibodies for the treatment of oncological diseases and disorders, infectious diseases, immune deficiencies, and autoimmune diseases

88864825

Trademark

Design

REGISTERED

Owner:

Serial:88864825

Filed:Apr 8, 2020

Classes:5

Registration:6343232

Registered:May 4, 2021

Goods & Services

GIGAGEN

Trademark

Word

REGISTERED

Owner:

Serial:88864823

Filed:Apr 8, 2020

Classes:5

Registration:6343231

Registered:May 4, 2021

Goods & Services

pharmaceutical and therapeutic preparations for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance; therapeutic antibodies for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance | pharmaceutical drug discovery; research and development in the field of antibody-based therapies; research and development of pharmaceuticals in the fields of oncology, immunology, infectious diseases, and organ, tissue, or cell transplant tolerance; Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics; scientific research in the nature of machine learning on single-cell data to identify and quantify cell type differences for the purpose of discovering novel targets; Medical and scientific research for the identification, preparation, and development of antibody libraries; DNA, protein, and antibody screening for scientific research purposes

MAGNIFY

Service Mark

Word

REGISTERED

Owner:

Serial:88808750

Filed:Feb 24, 2020

Classes:42

Registration:6342952

Registered:May 4, 2021

Goods & Services

Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics; pharmaceutical drug discovery; scientific research in the nature of machine learning on single-cell data to identify and quantify cell type differences for the purpose of discovering novel targets

SURGE

Service Mark

Word

REGISTERED

Owner:

Serial:88808747

Filed:Feb 24, 2020

Classes:42

Registration:6342951

Registered:May 4, 2021

Goods & Services

Medical and scientific research for the identification, preparation, and development of antibody libraries; DNA, protein, and antibody screening for scientific research purposes